PHARMATECA » Search Articles by Keyword
Found: 6 articles
| Article |
Edition |
|
N.V. Zhukova (1, 2), R.V. Orlova (1, 2), N.Yu. Antimonik (1), S.I. Kutukova (1, 3), N.P. Belyak (1, 2), O.V. Vasyusina (3), N.V. Popova (1)
The effectiveness of an integrated approach to the treatment of patients with melanoma with metastatic brain lessions: clinical observation
|
№7 / 2019
|
|
K.V. Orlova, L.V. Demidov
OPPORTUNITIES OF COMBINED TARGETED THERAPY WITH VEMURAFENIB AND COBIMETINIB IN METASTATIC BRAF-POSITIVE CUTANEOUS MELANOMA: LONG-TERM RESULTS OF CLINICAL TRIALS
|
№17 / 2017
|
|
D.R. Naskhletashvili
CLINICAL CASE O THE EFFECTIVE TREATMENT OF RELAPSE OF ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA WITH BRAF V600E MUTATION USING TARGET DRUG VEMURAFENIB
|
№17 / 2016
|
|
M.E. Abramov, O.O. Gordeeva, E.I. Borisova, S.L. Gutorov, G.V. Vyshinskaya
NEW REALITIES IN THE TREATMENT OF DISSEMINATED SKIN MELANOMA WITH BRAF MUTATION
|
№17 / 2016
|
|
K.V. Orlova, G.Yu. Kharkevich, L.V. Demidov
TREATMENT OF CANCER WITH BRAF V600 GENE MUTATION USING VEMURAFENIB
|
№18 / 2015
|
|
K.V. Orlova, G.Yu. Kharkevich, L.V. Demidov
MOLECULAR-GENETIC HETEROGENEITY OF SKIN MELANOMA AND ITS IMPORTANCE FOR THE DEVELOPMENT OF INDIVIDUAL APPROACHES TO THE TREATMENT
|
№17 / 2014
|
{"loading":"Loading...","close":"Close","yes":"Yes","no":"No","proceed":"Proceed","conf_del":"Do you really want to delete","cancel":"Cancel"}
Русский
